SSC
TEVA icon

Syverson Strege & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Syverson Strege & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-526
Closed -$4.66K – 558
2023
Q1 		$4.66K Buy
+526
New +$4.66K ﹤0.01% 351